OFFICIAL PUBLICATION OF

by its subsidiary APPco

Complaints over pharmacy cannabis prices

Chris Brooker 07/07/2021

The Department of Health says it has nothing to do with regulating the prices charged by pharmacies for medicinal cannabis products Complaints regarding clinic consultations and the prices charged for resultant prescriptions for medicinal cannabis products have nothing to do with it, says the Department of Health. The Department was responding to a Question on

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Complaints over pharmacy cannabis prices

Previous Govt reveals plans for COVID-19 vaccine indemnity scheme

Next Poor wages, lack of support sees mum leave community pharmacy

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Govt reveals plans for COVID-19 vaccine indemnity scheme

Next Poor wages, lack of support sees mum leave community pharmacy

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.